Corcept Therapeutics
CORT
#2078
Rank
$9.07 B
Marketcap
$86.10
Share price
1.71%
Change (1 day)
44.91%
Change (1 year)

Corcept Therapeutics (CORT) - Net assets

Net assets on the balance sheet as of September 2025 : $0.63 Billion USD

According to Corcept Therapeutics 's latest financial reports the company has $0.63 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Corcept Therapeutics - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$0.67 B34.12%
2023-12-31$$0.50 B0.97%
2022-12-31$$0.50 B33.54%
2021-12-31$$0.37 B-28.19%
2020-12-31$$0.52 B40.99%
2019-12-31$$0.37 B34.54%
2018-12-31$$0.27 B44.47%
2017-12-31$$0.19 B361.51%
2016-12-31$$41.37 M123.69%
2015-12-31$$18.49 M-645.99%
2014-12-31$-$3.39 Million-116.12%
2013-12-31$$21.01 M-65.98%
2012-12-31$$61.77 M77.48%
2011-12-31$$34.8 M63.84%
2010-12-31$$21.24 M-3.84%
2009-12-31$$22.09 M30.67%
2008-12-31$$16.9 M14.75%
2007-12-31$$14.73 M131.67%
2006-12-31$$6.36 M-76.08%
2005-12-31$$26.59 M-42.12%
2004-12-31$$45.94 M-245.99%
2003-12-31$-$31.48 Million43.45%
2002-12-31$-$21.94 Million-198.06%
2001-12-31$$22.37 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
$79.27 B 12,445.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$18.60 B 2,843.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$44.75 B 6,982.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
$23.85 B 3,674.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$93.09 B 14,632.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$51.90 B 8,114.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$0.46 Billion-171.43%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-$44.56 Million-107.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$6.05 B 858.49%๐Ÿ‡บ๐Ÿ‡ธ USA